Hypertriglyceridemia
📧 Sign up to get email alerts when something new happens for Hypertriglyceridemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Omega-3 Fatty Acids for High Triglycerides in HIV-infected Patients [Phase 4]
A Phase 4 trial evaluated omega-3 fatty acids for high triglycerides in HIV-infected patients; the study has completed and results were post…
-
CLINICAL_TRIALS trial_result · 2014-11-04Clinical Trial Update: Vascular and Metabolic Effects of Omega-3 Fatty Acids [Phase 4]
Phase 4 trial update on the vascular and metabolic effects of omega-3 fatty acids in hypertriglyceridemia; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2014-11-04Clinical Trial Update: Vascular and Metabolic Effects of Fenofibrate/Omega vs Fenofibrate [Phase 4]
Phase 4 trial evaluating vascular and metabolic effects of fenofibrate/omega versus fenofibrate in hypertriglyceridemia has completed.
-
FDA approval · 2014-11-03FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for fenofibrate, confirming approval of a generic fenofibrate product.
-
FDA approval · 2014-10-31FDA Approved: FENOFIBRATE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' generic fenofibrate under an Original Application.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-10-10Clinical Trial Update: Changes in Lipids and Safety of Raltegravir in HIV+ Patients With Hyperlipidemia While on Current Standard Therapy [Phase 3]
Phase 3 trial evaluating lipid changes and safety of raltegravir in HIV-infected patients with hyperlipidemia on current standard therapy. T…
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: TRIal For Efficacy of Capre on hyperTriglyceridemiA [Phase 2]
Grace Therapeutics Inc. completed a Phase 2 trial evaluating Capre for hypertriglyceridemia.
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: Effect of Statins on Lipid Levels Following the First Acute Coronary Event (MK-0000-204)
This completed clinical trial evaluated the effect of statin therapy on lipid levels after a first acute coronary event; results were posted…
-
FDA approval · 2014-08-14FDA Approved: VASCEPA — Supplemental Application (Amarin Pharma Inc.)
The FDA approved a supplemental application for Vascepa (icosapent ethyl) submitted by Amarin Pharma Inc., resulting in a labeling update re…
-
CLINICAL_TRIALS trial_result · 2014-08-13Clinical Trial Update: Supplementation of Dual Probiotic Strains Reduced Fasting Triglyceride and Enhanced Apolipoprotein A-V Levels [Phase 3]
A Phase 3 trial evaluating supplementation with two probiotic strains reported reduced fasting triglycerides and increased apolipoprotein A-…
-
CLINICAL_TRIALS trial_result · 2014-07-29Clinical Trial Update: Intervention With n-3 Polyunsaturated Fatty Acids (PUFA)-Supplemented Products in Moderate Hypertriglyceridemic Patients [NA]
A clinical trial evaluating omega-3 polyunsaturated fatty acid–supplemented products in adults with moderate hypertriglyceridemia has comple…
-
CLINICAL_TRIALS trial_result · 2014-07-29Clinical Trial Update: Effects Of Consumption Of A Highly Mineralized Sodium Bicarbonated Water On Blood Lipid Profile [NA]
A completed clinical trial evaluated the impact of drinking highly mineralized sodium bicarbonated water on blood lipid profiles in individu…
-
FDA approval · 2014-06-25FDA Approved: OMEGA-3-ACID ETHYL ESTERS — Supplemental Application (KD Pharma USA, Inc.)
FDA approved a supplemental application for Omega-3-acid ethyl esters (KD Pharma USA, Inc.), updating regulatory approval for this existing …
-
CLINICAL_TRIALS trial_result · 2014-06-12Clinical Trial Update: Effect of Omega-3 Fatty Acid Supplementation on Hypertriglyceridemia in HIV-infected Children [Phase 2]
Phase 2 trial evaluating omega-3 fatty acid supplementation for hypertriglyceridemia in HIV-infected children; the study was terminated.
-
FDA approval · 2014-06-05FDA Approved: LOVAZA — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for Lovaza (omega-3-acid ethyl esters) submitted by Waylis Therapeutics LLC.
-
CLINICAL_TRIALS trial_result · 2014-05-30Clinical Trial Update: Apolipoprotein CIII Reduction Via Colchicine [EARLY_Phase 1]
An early-phase trial completed evaluating colchicine as a strategy to reduce apolipoprotein CIII in hypertriglyceridemia. The study also rel…
-
CLINICAL_TRIALS trial_result · 2014-05-19Clinical Trial Update: An Efficacy and Safety Study of Omacor® in Taiwanese Hypertriglyceridemic Patients [Phase 3]
This Phase 3 efficacy and safety trial of Omacor in Taiwanese patients with hypertriglyceridemia has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-15Clinical Trial Update: Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV [NA]
A National Heart, Lung, and Blood Institute-sponsored trial evaluated acipimox for improving hyperlipidemia and insulin sensitivity in HIV-i…
-
FDA approval · 2014-05-14FDA Approved: LOVAZA — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for Lovaza (omega-3-acid ethyl esters) submitted by Waylis Therapeutics LLC.
-
CLINICAL_TRIALS research · 2014-05-07Clinical Trial Update: Fish Oil Study for High Triglyceride Levels in Children [Phase 2, Phase 3]
A completed Phase 2/Phase 3 clinical trial evaluating fish oil for lowering triglycerides in children with hypertriglyceridemia.
-
CLINICAL_TRIALS trial_result · 2014-04-25Clinical Trial Update: Efficacy and Safety Study of DHA-O in Adults With Hypertriglyceridemia [NA]
A completed clinical trial evaluating the efficacy and safety of DHA-O in adults with hypertriglyceridemia.
-
FDA approval · 2014-04-07FDA Approved: OMEGA-3-ACID ETHYL ESTERS — Original Application (KD Pharma USA, Inc.)
FDA approved the original application for Omega-3-Acid Ethyl Esters from KD Pharma USA, a generic version of the prescription therapy indica…
-
FDA approval · 2014-03-20FDA Approved: NIACIN — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' original abbreviated new drug application for NIACIN, a generic nicotinic acid product.
-
FDA approval · 2014-02-26FDA Approved: VASCEPA — Supplemental Application (Amarin Pharma Inc.)
FDA approves a supplemental application for Vascepa (icosapent ethyl), expanding its labeling to address cardiovascular risk reduction in ad…
-
CLINICAL_TRIALS trial_result · 2014-02-26Clinical Trial Update: Rosiglitazone And Fenofibrate Additive Effects on Lipids (RAFAEL) [Phase 4]
A Phase 4 trial evaluated additive effects of rosiglitazone and fenofibrate on lipid levels in hypertriglyceridemia; the study was terminate…